| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.420 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 1.000 | 10 | 0 | 2004 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
disease | 0.380 | None | 1.000 | 8 | 1 | 2009 | 2018 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.340 | None | 1.000 | 4 | 2 | 2011 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.320 | None | 0.667 | 2 | 0 | 2016 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1996 | 2007 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 1984 | 2012 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2017 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.240 | None | 1.000 | 4 | 0 | 2007 | 2014 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
L3MBTL histone methyl-lysine binding protein 2 | 0.729 | 0.308 | 1.0E-08 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2019 | ||||||||
|
L3MBTL histone methyl-lysine binding protein 1 | 0.729 | 0.269 | 1.5E-12 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2017 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2018 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2001 | 2018 | ||||||||
|
prominin 1 | 0.410 | 0.846 | 1.9E-22 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2006 | 2011 | ||||||||
|
hexokinase 1 | 0.542 | 0.731 | 0.91 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2012 |